121 related articles for article (PubMed ID: 8502514)
1. Estimation of central osteopenia in children with chronic polyarthritis treated with glucocorticoids.
Kotaniemi A; Savolainen A; Kautiainen H; Kröger H
Pediatrics; 1993 Jun; 91(6):1127-30. PubMed ID: 8502514
[TBL] [Abstract][Full Text] [Related]
2. Development of bone mineral density at the lumbar spine and femoral neck in juvenile chronic arthritis--a prospective one year followup study.
Kotaniemi A; Savolainen A; Kröger H; Kautiainen H; Isomäki H
J Rheumatol; 1998 Dec; 25(12):2450-5. PubMed ID: 9858444
[TBL] [Abstract][Full Text] [Related]
3. Growth retardation and bone loss as determinants of axial osteopenia in juvenile chronic arthritis.
Kotaniemi A
Scand J Rheumatol; 1997; 26(1):14-8. PubMed ID: 9057796
[TBL] [Abstract][Full Text] [Related]
4. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus.
Lilleby V; Lien G; Frey Frøslie K; Haugen M; Flatø B; Førre Ø
Arthritis Rheum; 2005 Jul; 52(7):2051-9. PubMed ID: 15986346
[TBL] [Abstract][Full Text] [Related]
5. Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.
Rudge S; Hailwood S; Horne A; Lucas J; Wu F; Cundy T
Rheumatology (Oxford); 2005 Jun; 44(6):813-8. PubMed ID: 15695300
[TBL] [Abstract][Full Text] [Related]
6. Weight-bearing physical activity, calcium intake, systemic glucocorticoids, chronic inflammation, and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis.
Kotaniemi A; Savolainen A; Kröger H; Kautiainen H; Isomäki H
Scand J Rheumatol; 1999; 28(1):19-26. PubMed ID: 10092160
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in children with juvenile chronic arthritis.
Cetin A; Celiker R; Dinçer F; Ariyürek M
Clin Rheumatol; 1998; 17(6):551-3. PubMed ID: 9890693
[TBL] [Abstract][Full Text] [Related]
8. Evaluation by dual X-ray absorptiometry (DXA) of bone mineral density in children with juvenile chronic arthritis.
Pereira RM; Corrente JE; Chahade WH; Yoshinari NH
Clin Exp Rheumatol; 1998; 16(4):495-501. PubMed ID: 9706436
[TBL] [Abstract][Full Text] [Related]
9. The ultrasonic assessment of osteopenia as defined by dual X-ray absorptiometry.
Herd RJ; Blake GM; Miller CG; Parker JC; Fogelman I
Br J Radiol; 1994 Jul; 67(799):631-5. PubMed ID: 8061996
[TBL] [Abstract][Full Text] [Related]
10. Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics.
Peris P; Parés A; Guañabens N; Pons F; Martínez de Osaba MJ; Caballería J; Rodés J; Muñoz-Gómez J
Alcohol Alcohol; 1992 Nov; 27(6):619-25. PubMed ID: 1292434
[TBL] [Abstract][Full Text] [Related]
11. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; Sanmartí A
Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336
[TBL] [Abstract][Full Text] [Related]
12. Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities.
Benbassat CA; Eshed V; Kamjin M; Laron Z
J Clin Endocrinol Metab; 2003 Oct; 88(10):4586-9. PubMed ID: 14557426
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
[TBL] [Abstract][Full Text] [Related]
14. Effect of mineral status and glucocorticoid use on bone mineral density in patients with Crohn's disease.
Pierote NR; Braz AF; Barros SL; Moita Neto JM; Parente JML; Silva MDCM; Beserra MS; Soares NRM; Marreiro DN; do Noscimento Nogueira N
Nutrition; 2018 Apr; 48():13-17. PubMed ID: 29469014
[TBL] [Abstract][Full Text] [Related]
15. Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis.
Felin EM; Prahalad S; Askew EW; Moyer-Mileur LJ
Arthritis Rheum; 2007 Mar; 56(3):984-94. PubMed ID: 17328076
[TBL] [Abstract][Full Text] [Related]
16. [Influence of glucocorticoids on bone mineral density in rheumatoid arthritis and seronegative spondyloarthropathies].
Savickiene A; Baranauskaite A
Medicina (Kaunas); 2003; 39(5):448-53. PubMed ID: 12794366
[TBL] [Abstract][Full Text] [Related]
17. Increased organ damage associated with deterioration in volumetric bone density and bone microarchitecture in patients with systemic lupus erythematosus on longterm glucocorticoid therapy.
Tang XL; Zhu TY; Hung VW; Qin L; Wong CK; Kun EW; Tam LS; Li EK
J Rheumatol; 2012 Oct; 39(10):1955-63. PubMed ID: 22896029
[TBL] [Abstract][Full Text] [Related]
18. Severe bone disease and low bone mineral density after juvenile renal failure.
Groothoff JW; Offringa M; Van Eck-Smit BL; Gruppen MP; Van De Kar NJ; Wolff ED; Lilien MR; Davin JC; Heymans HS; Dekker FW
Kidney Int; 2003 Jan; 63(1):266-75. PubMed ID: 12472792
[TBL] [Abstract][Full Text] [Related]
19. Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis.
Celiker R; Bal S; Bakkaloğlu A; Ozaydin E; Coskun T; Cetin A; Dinçer F
Rheumatol Int; 2003 May; 23(3):127-9. PubMed ID: 12739043
[TBL] [Abstract][Full Text] [Related]
20. [Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis].
Lurati A; Cimaz R; Gattinara M; Gerloni V; Teruzzi B; Salmaso A; Fantini F
Reumatismo; 2008; 60(3):224-9. PubMed ID: 18854886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
